SCHEMBL14561027

SCHEMBL14561027

CC(C)(C)CNc1cccc(-c2c(-c3ccc(F)cc3)nc3cc(CO)ccn23)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14561026 0.89 — —
SCHEMBL14561006 0.84 PRKD3 (0.64) —
SCHEMBL14561282 0.78 PRKD3 (0.63) —
SCHEMBL14561194 0.77 — —
SCHEMBL14561275 0.76 — —
SCHEMBL14572618 0.75 — —
SCHEMBL14561270 0.75 — —
SCHEMBL14561231 0.75 — —
SCHEMBL14561249 0.74 — —
SCHEMBL14561248 0.74 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7196095-B2 (Pyrimidinyl) (phenyl) substituted fused heteroaryl p38 inhibiting and PKG kinase inhibiting compounds MERCK & CO., INC. (US) 2007-03-27 — — US disclosed
US-7196095-B2 (Pyrimidinyl) (phenyl) substituted fused heteroaryl p38 inhibiting and PKG kinase inhibiting compounds MERCK & CO., INC. (US) 2007-03-27 — — US disclosed
Send feedback